260215
1,2-Epoxyhexadecane
technical grade, 85%
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
C16H32O
CAS Number:
Molecular Weight:
240.42
NACRES:
NA.23
PubChem Substance ID:
UNSPSC Code:
12162002
EC Number:
230-786-2
MDL number:
InChI key
DSZTYVZOIUIIGA-UHFFFAOYSA-N
InChI
1S/C16H32O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-15-17-16/h16H,2-15H2,1H3
SMILES string
CCCCCCCCCCCCCCC1CO1
grade
technical grade
assay
85%
refractive index
n20/D 1.446 (lit.)
bp
175-180 °C/12 mmHg (lit.)
mp
21-22 °C (lit.)
density
0.846 g/mL at 25 °C (lit.)
storage temp.
2-8°C
signalword
Warning
hcodes
Hazard Classifications
Aquatic Chronic 4 - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
Storage Class
10 - Combustible liquids
wgk
WGK 2
flash_point_f
199.4 °F - closed cup
flash_point_c
93 °C - closed cup
ppe
Eyeshields, Gloves, type ABEK (EN14387) respirator filter
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Shantipriya Khadka et al.
Electrophoresis, 37(23-24), 3160-3171 (2016-09-10)
A novel precursor monolithic capillary column referred to as "hydroxy monolith" or OHM was prepared by the in situ copolymerization of hydroxyethylmethacrylate (HEMA) with pentaerythritol triacrylate (PETA) yielding the neutral poly(HEMA-co-PETA) monolith. The neutral precursor OHM capillary thus obtained was
Khalid A Hajj et al.
Nano letters, 20(7), 5167-5175 (2020-06-05)
The clinical translation of messengerRNA (mRNA) drugs has been slowed by a shortage of delivery vehicles that potently and safely shuttle mRNA into target cells. Here, we describe the properties of a particularly potent branched-tail lipid nanoparticle that delivers mRNA
Rachel S Riley et al.
Science advances, 7(3) (2021-02-02)
Clinical advances enable the prenatal diagnosis of genetic diseases that are candidates for gene and enzyme therapies such as messenger RNA (mRNA)-mediated protein replacement. Prenatal mRNA therapies can treat disease before the onset of irreversible pathology with high therapeutic efficacy
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service